Skip to contentD
DexCom Inc
D
DXCMDexCom Inc Q2 2024 · 10-Q
Revenue$1.00B$1.00B+15.3% vs Q2 2023 Net Income$143.50M$143.50M+23.8% vs Q2 2023 EPS Diluted$0.35$0.35+25.0% vs Q2 2023 Gross Profit$626,700,000+14.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DexCom Inc · CIK 1093557 · Engraved from SEC EDGAR
Operating Cash Flowderived$279,400,000+46.8% Free Cash Flowderived$213,300,000+62.5% Margins · derivedGross margin62.4%−0.3 pt vs Q2 2023
Operating margin15.7%+1.0 pt vs Q2 2023
Net margin14.3%+1.0 pt vs Q2 2023
ended Jun 30, 2024 · filed Jul 25, 2024 · 25 d after period end